Common Contracts
2 similar License Agreement contracts by Poniard Pharmaceuticals, Inc.
EX-10.38 7 dex1038.htm SECOND AMENDMENT TO LICENSE AGREEMENT * Confidential Treatment has been requested for the marked portions of this exhibit pursuant to Rule 24B-2 of the Securities Exchange Act of 1934, as amended. CONFIDENTIAL – Execution Copy...License Agreement • May 5th, 2020
THIS SECOND AMENDMENT (“Second Amendment”), dated May 21, 2010 (“Second Amendment Effective Date”), is entered into by and between Sigma-Aldrich, Co. (“Sigma”) and Allozyne, Inc. (“Allozyne”).
SECOND AMENDMENT TO LICENSE AGREEMENT BETWEEN SIGMA-ALDRICH, CO. AND ALLOZYNE, INC.License Agreement • September 6th, 2011 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS SECOND AMENDMENT (“Second Amendment”), dated May 21, 2010 (“Second Amendment Effective Date”), is entered into by and between Sigma-Aldrich, Co. (“Sigma”) and Allozyne, Inc. (“Allozyne”).
